You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis
|
---|---|
Published in |
Cochrane database of systematic reviews, May 2013
|
DOI | 10.1002/14651858.cd000951.pub2 |
Pubmed ID | |
Authors |
Beverley Shea, Michael V Swinden, Elizabeth Tanjong Ghogomu, Zulma Ortiz, Wanruchada Katchamart, Tamara Rader, Claire Bombardier, George A Wells, Peter Tugwell |
Abstract |
Methotrexate (MTX) is a disease modifying antirheumatic drug (DMARD) used as a first line agent for treating rheumatoid arthritis (RA). Pharmacologically, it is classified as an antimetabolite due to its antagonistic effect on folic acid metabolism. Many patients treated with MTX experience mucosal, gastrointestinal, hepatic or haematologic side effects. Supplementation with folic or folinic acid during treatment with MTX may ameliorate these side effects. |
X Demographics
The data shown below were collected from the profiles of 34 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 3 | 9% |
Spain | 3 | 9% |
Japan | 3 | 9% |
France | 2 | 6% |
Sweden | 1 | 3% |
Brazil | 1 | 3% |
Mexico | 1 | 3% |
United Kingdom | 1 | 3% |
Portugal | 1 | 3% |
Other | 2 | 6% |
Unknown | 16 | 47% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 26 | 76% |
Practitioners (doctors, other healthcare professionals) | 3 | 9% |
Science communicators (journalists, bloggers, editors) | 3 | 9% |
Scientists | 2 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 330 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | <1% |
Netherlands | 1 | <1% |
Switzerland | 1 | <1% |
Canada | 1 | <1% |
Unknown | 325 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 53 | 16% |
Student > Master | 50 | 15% |
Student > Postgraduate | 29 | 9% |
Student > Ph. D. Student | 27 | 8% |
Other | 20 | 6% |
Other | 61 | 18% |
Unknown | 90 | 27% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 121 | 37% |
Pharmacology, Toxicology and Pharmaceutical Science | 25 | 8% |
Nursing and Health Professions | 21 | 6% |
Biochemistry, Genetics and Molecular Biology | 19 | 6% |
Agricultural and Biological Sciences | 12 | 4% |
Other | 34 | 10% |
Unknown | 98 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 56. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 June 2023.
All research outputs
#768,582
of 25,584,565 outputs
Outputs from Cochrane database of systematic reviews
#1,437
of 13,156 outputs
Outputs of similar age
#5,696
of 207,444 outputs
Outputs of similar age from Cochrane database of systematic reviews
#36
of 286 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,156 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.8. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 207,444 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 286 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.